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Refugee Health
the Middle East and sub-Saharan Africa.1
The Australian Government requires that refugees
ered for migration to Australia undergo a health asse
being issued with a visa. This assessment includes
HIV infection in those aged 15 years or over, a
tuberculosis infection (including a chest radiograph) 
than 11 years.2 An additional “fitness-to-fly” pre-depMJA • Volume 190 NumABSTRACT
• About 13 000 refugees are currently accepted for migration 
into Australia each year, many of whom have spent protracted 
periods living in extremely disadvantaged circumstances. 
As a result, medical practitioners are increasingly managing 
recently arrived refugees with acute and chronic infectious 
diseases.
• The Australasian Society for Infectious Diseases has 
formulated guidelines for the diagnosis, management and 
prevention of infection in newly arrived refugees. This article 
is an abridged version of the guidelines, which are available 
in full at <http://www.asid.net.au>.
• All refugees should be offered a comprehensive health 
assessment, ideally within 1 month of arrival in Australia, that 
includes screening for and treatment of tuberculosis, malaria, 
blood-borne viral infections, schistosomiasis, helminth 
infection, sexually transmitted infections, and other infections 
(eg, Helicobacter pylori) as indicated by clinical assessment; 
and assessment of immunisation status, and catch-up 
immunisations where appropriate.
• The assessment can be undertaken by a general practitioner 
or within a multidisciplinary refugee health clinic, with use 
of an appropriate interpreter when required. The initial 
assessment should take place over at least two visits: the first 
for initial assessment and investigation and the second for 
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review of results and treatment or referral.us
Un
geA tralia and New Zealand have obligations under the 1951ited Nations Convention relating to the Status of Refu-es and the 1967 Protocol Relating to the Status of
Refugees to assist in the relocation of individuals who are unable to
remain in their country of origin. Currently, about 13 000 refugees
migrate to Australia each year,1 with priority regions for individu-
als needing resettlement including southern and South-East Asia,
 being consid-
ssment before
 screening for
nd for active
in those older
arture assess-
ment is usually performed shortly before travelling to Australia.
Testing for and treatment of malaria and empiric treatment for
helminth infection have recently been added to the fitness-to-fly
assessment for many sub-Saharan African refugees. However, as
refugees bear a disproportionate burden from other acute and
chronic infectious diseases that may be undiagnosed or untreated
at the time of arrival in Australia,3-5 timely post-arrival screening
for infectious diseases and other common conditions in all refu-
gees is essential, to ensure not only the health of each refugee but
also the public health of the broader Australian community.
In recent years, migrant and refugee health service providers
have noted an increase in the number and variety of infectious
diseases in newly arrived refugees, particularly in those from sub-
Saharan Africa.3-5 These infections are often unfamiliar to local
medical practitioners, as many are not endemic to Australia. This
has led to a degree of uncertainty and concern among refugees,
health care providers and the wider community. How should we
screen for infection in refugees? Which tests should be performed?
What should we do with the results? What about catch-up
immunisations? The states and territories have developed their
1 Key general recommendations
• All refugees should be offered a comprehensive health 
assessment, ideally within 1 month of arrival in Australia. 
This should include:
¾ screening for and treatment of tuberculosis, malaria, blood-
borne viral infections, schistosomiasis, helminth infection, and 
sexually transmitted infections;
¾ testing for and treatment of other infections (eg, Helicobacter 
pylori) as indicated by clinical assessment; and
¾ assessment of immunisation status, and catch-up immunisations 
where appropriate.
• The assessment can be undertaken by a general practitioner or 
within a multidisciplinary refugee health clinic.
• An appropriate interpreter should be used when required.
• The initial assessment should take place over at least two visits: 
the first for initial assessment and investigation and the second 
for review of results and treatment or referral.
• Psychological, dental, nutritional, reproductive and 
developmental health issues (which are beyond the scope of 
these guidelines) should also be addressed at the post-arrival 
health assessment. ◆
* Other members of the Writing Group were Meredith Hansen-Knarhoi, Vicki 
Krause, Beverley-Ann Biggs, Christopher Lemoh, Jill Benson, Sarah Cherian, 
Jim Buttery and Georgia Paxton.
A working group determined a list of priority conditions and issues to be 
included in the guidelines, and 11 members were assigned section-writing 
responsibilities. First drafts of each section were internally reviewed and 
revised; second drafts were externally reviewed by seven experts in relevant 
fields, returned to section authors and compiled into a single document, 
with a recommendation table. The draft was circulated to stakeholders (the 
Communicable Diseases Network Australia [CDNA] and the Australasian 
Chapter of Sexual Health Medicine [AChSHM] of the Royal Australasian 
College of Physicians) and to all members of the Australasian Society for 
Infectious Diseases (ASID) for review. Comments from stakeholders were 
returned to authors, and the final document was prepared and endorsed by 
ASID, CDNA, the National Tuberculosis Advisory Committee and AChSHM. ◆ber 8 • 20 April 2009 421
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2 Summary of recommendations for the diagnosis, treatment and prevention of common infections in recently 
arrived refugees*
sAg = surface antigen. sAb = surface antibody. cAb = core antibody. eAg = e antigen. 
* Treatment recommendations graded according to National Health and Medical Research Council (NHMRC) levels of evidence.9 ◆
 Tuberculosis
Recommended screening test: Mantoux test or interferon- 
release assay
If positive:
• Refer to local tuberculosis (TB) service for exclusion of active TB 
infection and/or consideration of treatment of latent TB infection 
(Level I)
 Malaria
Recommended screening test: malaria thick and thin blood films and 
Plasmodium falciparum antigen test
If positive:
• Discuss urgently with local infectious disease service and refer for 
treatment
 Blood-borne viral infections
Recommended screening test: HIV serology
If positive:
• Refer to local HIV service
• Advise of transmission risk
• Ensure TB screening has been performed
• Ensure screening for other blood-borne viruses has been 
performed
Recommended screening test: hepatitis B (HB) serology (sAg/sAb/cAb)
If HBsAg positive:
• Request HBeAg and liver function tests (LFTs)
• If HBeAg positive OR LFT results abnormal, refer to local viral 
hepatitis management service
• Advise of transmission risk
• Immunise all non-immune household contacts
Recommended screening test: hepatitis C serology
If positive:
• Request LFTs and hepatitis C virus (HCV) RNA (qualitative)
• Advise of transmission risk
• If LFT results abnormal AND/OR HCV RNA detected, refer to local 
viral hepatitis management service
 Sexually transmitted infections
Recommended screening test: syphilis serology
If positive:
• Review history, including previous treatment
• Treat as per local guidelines
• Discuss cases of all children with positive serological test results for 
syphilis with paediatric infectious disease service
Recommended screening test: nucleic acid detection test for 
Chlamydia trachomatis and Neisseria gonorrhoeae
All adults and others who are sexually active or may have been sexually 
assaulted should be screened for chlamydia and gonorrhoea infection on 
first-void urine
 Helminth infection
Recommended screening test: Strongyloides serology
If positive:
• Ivermectin 200 μg/kg orally as a single dose, repeated 14 days 
after first dose (Level II)
• If patient is aged < 5 years, do not give ivermectin; refer to 
paediatric infectious disease service
Recommended screening test: full blood count (FBC) and/or 
faeces microscopy
If faeces readily obtainable OR symptoms present, faeces 
microscopy should be followed by directed treatment
If faeces not readily obtainable AND patient is asymptomatic:
• If no documented pre-departure albendazole therapy:
¾ Empiric single-dose albendazole (patient  10 kg, 200 mg; 
> 10 kg, 400 mg) (Level I)
¾ Repeat FBC in 8 weeks; if eosinophilia still present, 
investigate further or specialist referral
• If documented pre-departure albendazole therapy:
¾ No eosinophilia: no further treatment or follow-up
¾ Eosinophilia: repeat FBC in 8 weeks — if eosinophilia still 
present, investigate further or specialist referral
 Schistosomiasis
Recommended screening test: schistosomiasis serology
If positive:
• Praziquantel 20 mg/kg, two doses 4 hours apart (Level I) 
(30 mg/kg if patient is from South-East Asia) (Level II)
• Obtain stool and urine for ova examination
• Refer patients with chronic liver disease (including viral 
hepatitis), symptoms or signs for further assessment
 Other infections that may be detected at the health 
assessment — indications for testing
Helicobacter pylori infection
Adults with suspected peptic ulcer disease (based on symptoms):
• Non-invasive tests for H. pylori infection (eg, stool antigen test 
or urea breath test)
• If positive, treat as per current guidelines
Children with anorexia, poor weight gain or failure to thrive should 
be referred to a paediatric refugee health service for assessment
Uncommon infections (eg, filariasis, tungiasis)
Discussion with or referral to an adult or paediatric infectious 
disease specialist is recommended
 Immunisation
Catch-up immunisations for all ages in accordance with the 
Australian Standard Immunisation Schedule, unless there is written 
evidence of adequate immunisation; serological tests to detect 
existing immunity are not recommended
REFUGEE HEALTHown responses to these challenges, with approaches varying from
no or limited screening to comprehensive screening for both
common and rarer infections.3-7
In late 2005, the Communicable Diseases Network Australia
(CDNA) asked the Australasian Society for Infectious Diseases
(ASID) to formulate guidelines for the screening, treatment and
prevention of infections in recently arrived sub-Saharan African
refugees, with the aim of providing practical assistance to general
practitioners and others who provide health care services to this
population (see footnote on page 421 for details of the guideline
development process). Here, we summarise the major recommen-
dations of these guidelines, which are available in full on the ASID
website at <http://www.asid.net.au>.8 Treatment recommendations
have been graded according to National Health and Medical
Research Council (NHMRC) levels of evidence.9
Although the guidelines were originally written for refugees
originating from sub-Saharan Africa, many of the recommenda-
tions will apply to refugees from other regions. Each section of the
guidelines includes a discussion of issues specific to refugee
children. The guidelines have been endorsed by the CDNA, the
National Tuberculosis Advisory Committee, and the Australasian
Chapter of Sexual Health Medicine of the Royal Australasian
College of Physicians.
The key general recommendations of the guidelines are shown
in Box 1, and a summary of recommendations for testing for and
treatment of common infections in refugees is provided in Box 2.
More detailed recommendations for some of the most commonly
encountered infections are shown in Box 3 (tuberculosis, malaria
and schistosomiasis) and Box 4 (blood-borne viral infections [HIV,
hepatitis B and hepatitis C] and sexually transmitted infections).
Wherever possible, treatment recommendations are based on
published evidence; however, there is a clear need for further
research to develop a broader evidence base to underpin the
management of the complex health needs of refugees.
Newly arrived refugees have been through significant turmoil
and upheaval. Therefore, post-arrival health assessments must be
sensitive to their feelings of cultural disorientation, vulnerability
and sometimes fear and mistrust of authorities. We have recom-
mended a screening approach that can be performed by a single
venepuncture (see Box 2), avoiding multiple blood tests and
routine collection of other specimens wherever possible. We
believe that the guidelines strike a balance between identifying
important and treatable infections and overinvestigation.
These guidelines focus on infectious diseases. However, assess-
ment for infectious diseases is only one component of a compre-
hensive overall assessment that should also address psychological
health, nutritional status, sexual and reproductive health, dental
health, chronic disease, cancer screening, and childhood growth
and development. We refer readers to other recent Australian
publications for advice regarding these important issues,6,7,26,27
which are beyond the scope of these guidelines.
It is important to note that unless the granting of an individual’s
visa was contingent on a specific health undertaking, assessment
and screening is offered on a voluntary basis and following
informed consent. Refugee health assessments should always be
undertaken with an interpreter, either in person or by telephone.
The interpreter should not be related to the patient, and the need
for confidentiality should be emphasised. The Australian Govern-
ment provides the Translating and Interpreting Service (TIS) for
people who do not speak English and for those who need to
3 Detailed recommendations for tuberculosis, malaria 
and schistosomiasis*
 Tuberculosis (TB)
With the exception of those with documented past TB disease, all 
newly arrived refugees, including children, should be assessed for 
latent TB infection (LTBI), with the following plan:
• Testing is performed with the intention to treat.10
• Either a Mantoux test or a blood-based interferon-γ  release assay 
(IGRA) may be used for screening.11,12
• A Mantoux test result  10 mm in adults and children  5 years of 
age and  5 mm in those younger than 5 years or those who are 
HIV-infected is considered positive.
• Refer those with a positive Mantoux test or blood-based IGRA 
result to local TB service for exclusion of active TB infection and 
consideration of treatment of LTBI.13 (Level I)
• Refugees known to be HIV-infected should have a two-step 
Mantoux test. If the second test result remains < 5 mm, specialist 
advice should be sought from TB/HIV services.
• TB (active disease or latent infection) should be managed by 
clinicians experienced in doing so as part of a centralised, 
coordinated TB service.
 Malaria
• All refugees, including those who have had documented testing 
and/or treatment for malaria at the time of pre-departure 
assessment,14 should be tested for malaria after arrival in Australia 
(except those who have never resided in or travelled through a 
region where malaria occurs).
• Testing should be performed both by thick and thin blood films 
AND an antigen-based rapid detection test.15
• All cases of malaria should be treated by or in consultation with a 
specialist infectious disease service.
• Falciparum malaria in adults resettled in malaria non-receptive 
areas of Australia may be treated in the outpatient setting if the 
following criteria are satisfied: asymptomatic or minimally 
symptomatic, not pregnant, and no indicators of severe malaria 
(altered consciousness, jaundice, oliguria, severe anaemia or 
hypoglycaemia, parasite count > 100 000/μL or > 2%, or patient is 
vomiting or acidotic).16 (Level IV)
• Cases of malaria in children should be urgently discussed with a 
paediatric infectious disease service.17
 Schistosomiasis
• Serological tests for schistosomiasis should be performed for all 
recently arrived African and South-East Asian refugees.18,19
• Those with negative results of serological tests do not require 
further investigation.
• Those with positive results of serological tests should be treated 
presumptively:
¾ Praziquantel 40 mg/kg in two doses of 20 mg/kg, 4 hours apart 
for refugees from Africa.20-22 (Level I)
¾ Praziquantel 60 mg/kg in two doses of 30 mg/kg, 4 hours apart 
for refugees from South-East Asia.23 (Level II)
• Those with positive results of serological tests should also have 
faeces and urine examined for schistosoma ova to determine if 
further follow-up is required (refer to full guidelines8 for details).
* Treatment recommendations graded according to National Health and 
Medical Research Council (NHMRC) levels of evidence.9 ◆MJA • Volume 190 Number 8 • 20 April 2009 423
REFUGEE HEALTHcommunicate with them. This service is available free of charge to
practitioners who provide a Medicare service within a private
practice to permanent residents or citizens who do not speak
English. The service is also available within hospitals or govern-
ment-funded clinics, but must be paid for in these settings. The
TIS Doctors Priority Line (tel: 1300 131 450) should be used to
access this service.
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